Recombinant polypeptide production methods
Herein is reported a method for producing a fusion-polypeptide comprising the steps of a) cultivating a mammalian cell comprising a nucleic acid encoding a variant fusion-polypeptide wherein the amino acid sequence of the fusion-polypeptide has been modified by replacing in a pro-fusion-polypeptide the endogenous protease cleavage site between the pro-peptide and the fusion-polypeptide with an exogenous (with respect to the origins of the parts of the fusion-polypeptide) or artificial protease cleavage site, and b) recovering the fusion-polypeptide or fusion-pro-polypeptide from the cell or the cultivation medium and thereby producing the (recombinant) fusion-polypeptide.
1. A method for producing a recombinant polypeptide, comprising the following steps:
cultivating a mammalian cell comprising a nucleic acid encoding the polypeptide as a variant pro-polypeptide which is a fusion polypeptide of a pro-segment and the polypeptide wherein an enzymatic cleavage site between the pro-segment and the polypeptide but not the pro-segment is replaced by an IgA protease cleavage site,
recovering the variant pro-polypeptide from the cell or the cultivation medium,
cleaving the variant pro-polypeptide, and thereby producing the recombinant polypeptide,
wherein the fusion-polypeptide comprises a biologically active entity, a linker peptide, and a monovalent binding entity which binds to a blood-brain-barrier (BBB) receptor.
2. The method according to claim 1 , wherein the cleavage of the variant pro-polypeptide is during purification of the polypeptide.
3. The method according to claim 1 , wherein the polypeptide is a neurotrophic factor.
4. The method according to claim 1 , wherein an exogenous protease is added to the cultivation medium.
5. The method according to claim 1 , wherein an exogenous protease is co-expressed in the cultivation medium.
6. A method for producing a recombinant polypeptide, comprising the following steps:
cultivating a mammalian cell comprising a nucleic acid encoding the polypeptide as a variant pro-polypeptide which is a fusion polypeptide of a pro-segment and the polypeptide wherein an enzymatic cleavage site between the pro-segment and the polypeptide but not the pro-segment is replaced by an IgA protease cleavage site, recovering the variant pro-polypeptide from the cell or the cultivation medium, cleaving the variant pro-polypeptide, and thereby producing the recombinant polypeptide,
wherein the fusion-polypeptide comprises a biologically active entity, a linker peptide, and a monovalent binding entity which binds to a blood-brain-barrier (BBB) receptor, and wherein the linker peptide comprises one or more negatively charged amino acid residues.
7. The method according to claim 6 , wherein the cleavage of the variant pro-polypeptide is during purification of the polypeptide.
8. The method according to claim 6 , wherein the polypeptide is a neurotrophic factor.
9. The method according to claim 6 , wherein an exogenous protease is added to the cultivation medium.
10. The method according to claim 6 , wherein an exogenous protease is co-expressed in the cultivation medium.